# Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

> **NCT07352566** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 10 (estimated)

## Conditions studied

- Psoriasis
- Atopic Dermatitis

## Interventions

- **DEVICE:** In situ cutaneous microdevice
- **DRUG:** Triamcinolone
- **DRUG:** 5-Fluorouracil
- **DRUG:** Calcipotriene
- **DRUG:** Tapinarof
- **DRUG:** Crisaborole
- **DRUG:** Tacrolimus
- **DRUG:** Adalimumab
- **DRUG:** Etanercept
- **DRUG:** Certolizumab
- **DRUG:** Infliximab
- **DRUG:** Secukinumab
- **DRUG:** Ixekizumab
- **DRUG:** Apremilast
- **DRUG:** Risankizumab
- **DRUG:** Ustekinumab
- **DRUG:** Hydroxychloroquine
- **DRUG:** Methotrexate
- **DRUG:** Mycophenolate
- **DRUG:** Azathioprine

## Key facts

- **NCT ID:** NCT07352566
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2030-06-01
- **Final completion:** 2030-06-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07352566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07352566, "Utilization of a Microdevice for Psoriasis and Atopic Dermatitis". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07352566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*